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Abstract 
Twenty-one  Lactobacillus  isolates  from “Sha’a” (a maize  –  based fermented 
beverage) and “Kossam” (traditionally fermented cow milk) were selected in 
accordance with their antagonistic activities and tested for their bacterio-
cinogenic potential as well as safety properties. These isolates  were prelim-
inarily  identified as Lactobacillus plantarum (62%),  Lactobacillus rhamnosus 
(24%),  Lactobacillus fermentum (10%)  and  Lactobacillus coprophilus  (4%) 
based on phenotypic characteristics and rep-PCR genomic fingerprinting. 
Twelve (57.1%) out of the 21 strains tested were found to be bacteriocin 
producers, as revealed by the sensitivity of their antimicrobial substances to 
proteolytic enzymes (Trypsin, Proteinase K) and inhibition of other Lactobacillus 
spp. These bacteriocinogenic strains showed no positive haemolytic and 
gelatinase activities and proved to be sensitive to penicillin G, ampicillin, 
tetracycline, erythromycin, amoxicillin, chloramphenicol, co-trimoxazole and 
doxycyclin, but resistant to ciprofloxacin and gentamicin.  The bacteriocins 
showed a broad inhibitory activity against Gram-positive and Gram-negative 
pathogenic bacteria, several of which are classified as especially dangerous by 
the World  Health Organization,  as well as Multidrug-resistant strains. These 
include Staphylococcus aureus, Salmonella enterica subsp. enterica serovare 190  P. M. Kaktcham et al.:   
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Typhi, Bacillus cereus, Streptococcus mutans, Escherichia coli, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Shigella flexneri. These Lactobacillus 
strains are promising candidates for use as protective cultures in food 
fermentation.  
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Introduction 
Lactic acid bacteria (LAB) have been used in the processing of fermented foods for 
centuries [1]. They are part of the daily diet of virtually all people around the world. Most 
often, production of indigenous fermented foods depends on naturally occurring LAB. They 
have the ability to produce a variety of antimicrobial substances such as organic acids, 
hydrogen peroxide and bacteriocins. Bacteriocins produced by LAB are ribosomally 
synthesized extracellular small peptides that exhibit bactericidal or bacteriostatic activity 
against genetically closely related bacteria [2]. They are the most important, because, due 
to their proteinaceous nature, they are rapidly digested by proteases in human and animal 
gastrointestinal tracts, unlike current antibiotics [3]. Given that the prevalence of multidrug-
resistant (MDR) and especially dangerous pathogenic bacteria is increasing at an alarming 
rate [4], bacteriocins or bacteriocin-like substances could be a novel approach for an 
effective drug. In addition, fermented foods are also associated with LAB which possess 
remarkable properties for their use as starter cultures or probiotics. They are usually used 
for their health benefits in animal or human,  and it is recommended that antibiotic 
resistance patterns and opportunistic virulence properties should be tested to document 
their safety [5]. In fact, antibiotic-resistant LAB could horizontally transfer their genes or 
determinants to opportunistic pathogens within the gut microbiota [6].  
In  the  western highlands region  of Cameroon, two traditional fermented foods named 
“Kossam” (fermented cow  milk) and “Sha’a” (a maize-based beverage) are widely 
produced and consumed. While they constitute a natural reservoir of LAB which have not 
yet been identified and studied for their antimicrobial activity, there is obvious evidence 
that LAB strains from different origins could possess antimicrobial activities at different 
levels. It became important to initiate comprehensive studies to screen antimicrobial and 
safety properties of the wild LAB microbiota from these natural reservoirs for their 
antimicrobial applications. This research is important in order to valorise indigenous strains 
and also to propose another alternative to satisfy the increasing request of the market with 
novel bacteriocinogenic characterized LAB strains. 
In the present study, lactobacilli with antagonistic activity isolated from “Kossam” and 
“Sha’a” were characterized and identified. They were also evaluated for bacteriocin 
production as well as some safety properties such as antibiotic susceptibility, haemolysis 
and gelatinase activities. 
 
   Antimicrobial and Safety Properties of Lactobacilli  191 
Sci Pharm. 2012; 80: 189–203 
Results and Discussion 
Isolation of Lactobacillus strains and inhibitory activity 
A total of 90  Lactobacillus  isolates was obtained. Sixty (75%) out of the 90  isolates 
inhibited the growth of the other lactobacilli strains, as well as Staphylococcus aureus 
ATCC25923,  Salmonella enterica subsp.  enterica  serovare Typhi  ATCC6539, 
Pseudomonas aeruginosa ATCC27853, Escherichia coli, Klebsiella pneumoniae, Proteus 
mirabilis and Shigella flexneri. From these 60 isolates, 21 (35%) with largest spectra and 
zone of inhibition were selected and used for further assays. 
Tab. 1.   Comparison of the identification of Lactobacilli isolates using API system and 
rep-PCR profiles. 
Isolates  Identification by API system  
(% similarity) 
Identification by rep-PCR  
(% identity) 
1S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (72.5%) 
2S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (80.0%) 
3S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (75.8%) 
4S  Lactobacillus plantarum (75.9%)  Lactobacillus plantarum (74.6%) 
5S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (74.9%) 
6S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (74.5%) 
7S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (72.6%) 
8S  Lactobacillus plantarum (99.9%)  Lactobacillus plantarum (73.0%) 
9S  Lactobacillus plantarum (72.0%)  Lactobacillus plantarum (72.9%) 
10S  Lactobacillus plantarum (79.0%)  Lactobacillus plantarum (73.9%) 
11S  Lactobacillus plantarum (77.0%)  Lactobacillus plantarum (73.6%) 
15S  Lactobacillus plantarum (85.9%)  Lactobacillus plantarum (65.8%) 
16S  Lactobacillus plantarum (89.9%)  Lactobacillus plantarum (65.7%) 
18S   Lactobacillus rhamnosus (97.5%)  Unidentified 
19S  Lactobacillus rhamnosus (86.0%)  Unidentified 
1K  Lactobacillus rhamnosus (86.0%)  Lactobacillus rhamnosus (73.1%) 
3K  Lactobacillus rhamnosus (88.5%)  Lactobacillus rhamnosus (65.0%) 
1K1  Lactobacillus rhamnosus (96.5%)  Lactobacillus rhamnosus (70.4%) 
2K  Lactobacillus fermentum (74.1%)  Lactobacillus fermentum (69.2%) 
13S*  Lactobacillus coprophilus (77.0%)  Lactobacillus fermentum (68.4%) 
1SB1  Lactobacillus coprophilus (97.0%)  unidentified 
*…API result does not match with rep-PCR identification in this case. 
 
Preliminary identification of strains 
The microscopic examination reveals that the tested isolates have cellular rod form, 
associated in pairs, heap or chain. In addition, all the isolates were found to be gram-
positive and catalase-negative. Based on the fermentative profile, data from each isolate 
was compared with profiles obtained from recognized test organisms,  and it was 
determined that the isolates can be classified as Lb.  plantarum,  Lb.  rhamnosus,  Lb. 
coprophilus and Lb. fermentum (Table 1). 192  P. M. Kaktcham et al.:   
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From the 21 isolates tested and identified using phenotypic characteristics, 18 were 
identified by rep-PCR. The dendrogram generated from BOXA1R-PCR banding patterns 
are given in Figure 1. The isolates belonging to group II Lactobacillus spp. were classified 
into 2 clusters. Cluster 1 consisted of Lb. rhamnosus (1K, 1K1, 3K) at r = 69.5%, whereas 
cluster 2 grouped Lb. plantarum strains (1S, 2S, 3S, 4S, 5S, 6S, 7S, 8S, 9S, 10S, 11S, 
15S, 16S) at r = 73.06% (Figure 1).  
 
 
Fig. 1.   Dendrograms generated from Box-PCR fingerprinting of the isolated Group II 
and Group III Lactobacillus spp. The dendrogram was constructed using the 
unweighted pair group method using arithmetic averages with correlation levels 
expressed as percentage.  
The isolates belonging to the Group III Lactobacillus spp (13S, 2K) were similar to strains 
of Lb. fermentum at r = 68.8%. The strains of each cluster also showed characteristic 
banding pattern with slight differences, demonstrating their close relatedness. The majority 
of  Lactobacillus  strains with antagonistic activity was found in “Sha’a” where  a 
predominance  of  Lactobacillus plantarum  was  observed, whereas in “Kossam”, 
Lactobacillus rhamnosus  was predominant. This result is in accordance with recent 
investigations showing that LAB with antagonistic activities are largely distributed in cereal-
based fermented foods [21, 22]. Rep-PCR confirms all phenotypic results, except for one 
strain (13S). After identification by API system this strain has higher percent similarity with 
Lactobacillus coprophilus  than  Lactobacillus fermentum, but it  was identified as 
Pearson correlation [0.0%-100.0%]
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Lactobacillus fermentum by rep-PCR. Such situations were also found by authors such as 
Chagnaud et al. [23], Mohamed et al. [9] and Terzic-Vidojevic et al. [24]. This shows that 
phenotypic tests sometimes suffer from lack of reproducibility and discriminatory power.  
Tab. 2.   Effect of proteolytic and non-proteolytic enzymes on the activity of cell free 
supernatants. 
  Mean Inhibition Zone diameter (mm)
a 
Strains  Control  Trypsin  Proteinase K  α- Amylase  Lipase  Lysozyme 
Lb. plantarum 2S  12.5  0 (−)  0 (−)  12 (+)  12.5 (+)  12.5 (+) 
Lb. plantarum 5S  13.5  0 (−)  0 (−)  13.5 (+)  13.5 (+)  13.5 (+) 
Lb. plantarum 6S  16  0 (−)  0 (−)  15.5 (+)  15.5 (+)  16 (+) 
Lb. plantarum 7S  13  0 (−)  0 (−)  12.5 (+)  12.5 (+)  12.5 (+) 
Lb. plantarum 8S  12.5  0 (−)  0 (−)  12.5 (+)  12.5 (+)  12.5 (+) 
Lb. plantarum 9S  13  0 (−)  0 (−)  13 (+)  13 (+)  13 (+) 
Lb. pantarum 10S  8  0 (−)  0 (−)  8 (+)  8 (+)  8 (+) 
Lb. plantarum 11S  13  0 (−)  9 (+)  13 (+)  13 (+)  13 (+) 
Lb. plantarum 16S  12  0 (−)  0 (−)  12 (+)  12 (+)  12 (+) 
Lb. rhamnosus 18S  12  0 (−)  0 (−)  12 (+)  12 (+)  12 (+) 
Lb. rhamnosus 1K  14  0 (−)  0 (−)  14 (+)  14 (+)  14 (+) 
Lb. fermentum 2K  13  0 (−)  0 (−)  13 (+)  13 (+)  13 (+) 
a…Inhibition zone diameters are means of three assays and include the diameter of the wells (6 mm). 
 
 
Fig. 2.   Antimicrobial activity assessed by halo formation of bacteriocin from strain Lb. 
plantarum 6S treated with enzymes.  
C1: CFS in Tris-HCl buffer, pH 8.0 (untreated).  
C: CFS in Phosphate buffer, pH 7.0 (untreated).  
T: CFS treated with Trypsin (1 mg/ml).  
A: CFS treated with α-Amylase (1 mg/ml).  
Li: CFS treated with Lipase (1 mg/ml).  
Ly: CFS treated with Lysozyme (1 mg/ml). 
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Screening for bacteriocin producing strains 
Using combination of Triple-agar layer method and AWDA, 12 (57.1%) out of the 21 
strains tested were found to be bacteriocin producers. Complete inactivation was observed 
when the CFS were treated by proteolytic enzymes, thus confirming the proteinaceous 
nature of the inhibitory substances. Treatment with α-Amylase and Lipase did not affect 
the antimicrobial activity, suggesting that the bacteriocins are not attached to carbohydrate 
or lipid moieties (Table 2 and Figure 2). 
Tab. 3.   Susceptibility of Lactobacillus strains to antibiotics by disc diffusion test 
  Inhibition Diameters (mm)
a 
Strains  AMP10  ERY15  PEN10  CHL30  TET30 
Lb. plantarum 2S  28 (S)  30 (S)  23 (S)  22 (S)  22 (S) 
Lb. plantarum 5S  31 (S)  27 (S)  22 (S)  20 (I)  20 (I) 
Lb. plantarum 6S  30 (S)  30 (S)  23 (S)  25 (S)  26 (S) 
Lb. plantarum 7S  28 (S)  30 (S)  27 (S)  25 (S)  23 (S) 
Lb. plantarum 8S  31 (S)  28 (S)  30 (S)  37 (S)  22 (S) 
Lb. plantarum 9S  34 (S)  30 (S)  25 (S)  25 (S)  25 (S) 
Lb. plantarum 10S  28 (S)  26 (S)  21 (S)  25 (S)  20 (I) 
Lb. plantarum 11S  28 (S)  27 (S)  22 (S)  25 (S)  18 (I) 
Lb. plantarum 16S  27 (S)  27 (S)  20 (I)  27 (S)  22 (S) 
Lb. rhamnosus 18S  35 (S)  30 (S)  22 (S)  27 (S)  29 (S) 
Lb. rhamnosus 1K  35 (S)  32 (S)  24 (S)  22 (S)  25 (S) 
Lb. fermentum 2K  27 (S)  28 (S)  26 (S)  25 (S)  21 (S) 
  Inhibition Diameters (mm)
a 
  GEN30  CIP10  AMO10  COT25  DOX30 
Lb. plantarum 2S  13 (R)  13 (R)  30 (S)  22 (S)  21 (S) 
Lb. plantarum 5S  13 (R)  7 (R)  30 (S)  17 (I)  20 (I) 
Lb. plantarum 6S  11 (R)  10 (R)  28 (S)  20 (I)  26 (S) 
Lb. plantarum 7S  12 (R)  12 (R)  30 (S)  22 (S)  22 (S) 
Lb. plantarum 8S  14 (R)  12 (R)  28 (S)  25 (S)  24 (S) 
Lb. plantarum 9S  22 (S)  14 (R)  33 (S)  20 (I)  29 (S) 
Lb. plantarum 10S  16 (I)  7 (R)  25 (S)  23 (S)  23 (S) 
Lb. plantarum 11S  18 (I)  12 (R)  26 (S)  21 (S)   25 S) 
Lb. plantarum 16S  14 (R)  11 (I)  28 (S)  20 (I)  25 (S) 
Lb. rhamnosus 18S  21 (S)  14 (R)  32 (S)  18 (I)  28 (S) 
Lb. rhamnosus 1K  20 (I)  15 (R)  29 (S)  16 (I)  26 (S) 
Lb. fermentum 2K  16 (I)  11 (R)  25 (S)  24 (S)  26 (S) 
AMO10: Amoxicillin 10µg; AMP10: Ampicillin 10µg; COT25: Co-trimoxazole 
(Trimethoprim/Sulfamethoxazole) 1.25+23.75= 25µg; CHL30: Chloramphenicol 
30µg; CIP10: Ciprofloxacin 10 µg; DOX30: Doxycyclin 30µg; ERY15: Erythromycin 
15µg; PEN10: Penicillin G 10µg; TET30: Tetracycline 30 µg; GEN30: Gentamicin 30µg 
(CLSI, 2011). 
a…Inhibition Zone Diameters are means from triplicate determinations; Diameters of 
the discs are inclusive (6mm); S…Sensitive; I…Intermediate; R…Resistant. 
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Inhibition of sensitive strain of Lactobacillus plantarum  confirmed that the inhibitory 
substances were bacteriocins. This study reports for the first time the characterization of 
bacteriocin-producing LAB isolated from “Sha’a” and traditionally fermented cow milk from 
Cameroon. Although many studies reported bacteriocin production by LAB worldwide, few 
strains of Lactobacillus fermentum were listed [25, 26]. 
Safety attributes of bacteriocin-producing strains 
All 12 strains assayed showed no positive haemolysis and gelatinase activity. With respect 
to  haemolysis  activity,  these  strains  were  found  to  be  γ-haemolytic. Results of the 
antibiotic susceptibility of strains are listed in Tables 3 and 4.  
Tab. 4.   MIC values (in μg/ml) of antibiotics against Lactobacillus strains.  
  AMP  PEN  ERY  CHL  TET 
Strains  MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
Lb. plantarum 2S  0.5  2  2  ND  <0.25  1  2  8  8  32 
Lb. plantarum 5S  0.5  2  2  ND  <0.25  1  2  8  8  32 
Lb. plantarum 6S  0.5  2  1  ND  <0.25  1  2  8  8  32 
Lb. plantarum 7S  0.5  2  1  ND  <0.25  1  2  8  16  32 
Lb. plantarum 8S  1  2  2  ND  <0.25  1  2  8  8  32 
Lb. plantarum 9S  1  2  1  ND  <0.25  1  4  8  16  32 
Lb. plantarum 10S  0.5  2  1  ND  <0.25  1  2  8  8  32 
Lb. plantarum 11S  0.5  2  1  ND  <0.25  1  4  8  8  32 
Lb. plantarum 16S  0.5  2  1  ND  <0.25  1  2  8  16  32 
Lb. rhamnosus 18S  0.5  4  1  ND  <0.25  1  2  4  8  8 
Lb. rhamnosus 1K  0.5  4  2  ND  <0.25  1  2  4  16  8 
Lb. fermentum 2K  0.5  1  1  ND  <0.25  1  2  4  8  8 
  GEN  AMO  CIP  COT  DOX 
  MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
MIC 
µg/ml 
MIC 
BP* 
Lb. plantarum 2S  64  16  1  ND  64  ND  32  ND  1  ND 
Lb. plantarum 5S  64  16  0.5  ND  128  ND  32  ND  2  ND 
Lb. plantarum 6S  64  16  1  ND  64  ND  32  ND  2  ND 
Lb. plantarum 7S  64  16  0.5  ND  64  ND  64  ND  4  ND 
Lb. plantarum 8S  64  16  0.5  ND  64  ND  64  ND  4  ND 
Lb. plantarum 9S  64  16  1  ND  64  ND  64  ND  4  ND 
Lb. plantarum 10S  32  16  0.5  ND  128  ND  64  ND  4  ND 
Lb. plantarum 11S  64  16  0.5  ND  64  ND  32  ND  4  ND 
Lb. plantarum 16S  64  16  2  ND  64  ND  32  ND  4  ND 
Lb. rhamnosus 18S  64  16  0.5  ND  64  ND  32  ND  4  ND 
Lb. rhamnosus 1K  64  16  0.5  ND  64  ND  64  ND  4  ND 
Lb. fermentum 2K  64  16  0.5  ND  64  ND  64  ND  2  ND 
*MIC BP = Minimal Inhibitory Concentration Breakpoints, according to European Food Safety Authorities [5]. 
ND…Not Defined. 
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Based on the disc diffusion test results, all the strains (100%) were susceptible to inhibitors 
of the cell wall synthesis (penicillin G, ampicillin and amoxicillin); they were also all 
susceptible to chloramphenicol and erythromycin. Sixty-six percent  showed moderate 
susceptibility to tetracycline and doxycyclin, whereas 50% were resistant to gentamicin as 
far as inhibitors of protein or mRNA synthesis were concerned. The strains showed 
susceptibility (50%) and moderate susceptibility (50%) to co-trimoxazole, but were all 
resistant (100%) to ciprofloxacin, these antibiotics belonging to the group of nucleic acid 
synthesis’s inhibitors. 
With regard to MIC results, the strains showed resistance (100%) only to gentamicin as 
revealed by the  comparison with the EFSA’s breakpoints. According to the ISO’s 
epidemiological cut-off values, two out of the 10 Lb. plantarum strains were recorded with 
MICs for ciprofloxacin above the quality control (QC) range. For all the Lb. rhamnosus 
strains, only the MICs for gentamicin and ciprofloxacin were above the QC range. Safety is 
one of the recommended attributes in guidelines on evaluation for probiotics and other 
LAB to be used as food additives [5]. Haemolysis activity would break down the epithelial 
layer while gelatinase activity would derange the mucoid lining interfering with the normal 
functioning of these very important linings across which many physiological substances 
are exchanged and would cause pathways for infections. None of the strains showed 
haemolysis or gelatinase activity, and these results were in accordance with those of Kalui 
et al.  [27]  for  Lb. plantarum  strains,  Lb. rhamnosus strains and Enterococcus faecium 
ET05. A key requirement for these food additives LAB strains is that they should not carry 
transferable antibiotic resistance genes. Transferable resistance genes may pose a risk, 
as they can be transferred to pathogenic bacteria [28]. From the 10 antibiotics tested, 
some strains were found to be resistant only to two of them, ciprofloxacin and gentamicin. 
Such cases were also reported by other authors such as Elkins and Mullins, [29]; Herreros 
et al [30]; Rojo-Bezares et al. [31] who found resistance of Lactobacilli to ciprofloxacin, 
gentamicin and other aminoglycosides. These resistances are natural and intrinsic 
resistances, probably due to cell wall structure and membrane impermeability, 
complemented in some cases by potential efflux mechanisms. Intrinsic resistance is not 
horizontally transferable and poses no risk in non-pathogenic bacteria [32]. Furthermore, 
following the EUCAST definition of an epidemiological value [20], our strains can be 
categorized as wild type organisms (free of acquired and mutational resistance 
mechanisms). Therefore, all the strains tested in our study are considered to be safe. 
Spectrum of Inhibitory activity 
The inhibitory spectrum of the bacteriocins produced by selected strains is presented in 
Table 5.  
The bacteriocins showed a relatively wide inhibition spectrum, inhibiting the growth of a 
number of Gram-positive and Gram-negative bacteria including species of the genera 
Lactobacillus, Streptococcus, Salmonella, Shigella, Bacillus, Staphylococcus, Escherichia, 
Pseudomonas  and  Klebsiella. However, no activity was detected against many other 
Lactobacillus  strains and the  Enterococcus faecium  strain  tested.  Interestingly, some 
bacteriocins were active against multidrug-resistant (MDR) strains of S. aureus and E. coli. 
Multidrug-resistant bacteria have emerged as serious pathogens over the past decade 
and, despite major research efforts aimed at finding an effective drug, increasing 
resistance has compromised therapy [33].    Antimicrobial and Safety Properties of Lactobacilli  197 
Sci Pharm. 2012; 80: 189–203 
Tab. 5.   Antibacterial spectrum of activity of bacteriocins produced by selected strains. 
     Bacteriocin Activity of Producer strains 
Indicator 
strains 
Source  Growth 
conditions 
2S  5S  6S  7S  8S  9S  10S 11S 16S 18S 1K  2K 
lactic acid bacteria 
Lb. plantarum 
3S 
Our 
isolate  MRS
c,30°C  ++  ++  +++  ++  ++  ++  +  ++  ++  ++  ++  ++ 
Lb. plantarum 
9S 
Our 
isolate  MRS,30°C  −  −  −  −  −  −  −  −  −  −  −  − 
Lb. plantarum 
29V 
Our 
collection MRS,30°C  −  −  −  −  −  −  −  −  −  −  −  − 
Lb. rhamnosus 
18S 
Our 
isolate  MRS,30°C  −  −  −  −  −  −  −  −  −  −  −  − 
Lb. rhamnosus 
1K 
Our 
isolate  MRS,30°C  −  −  −  −  −  −  −  −  −  −  −  − 
Lb. fermentum 
2K 
Our 
isolate  MRS,30°C  −  −  −  −  −  −  −  −  −  −  −  − 
Enterococcus 
faecium 
DSM
a 
13596  BHI
d,37°C  −  −  −  −  −  −  −  −  −  −  −  − 
Gram-positive pathogenic bacteria 
Staphylococcus 
aureus 
ATCC 
25923  BHI, 37°C  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++ 
Staphylococcus 
aureus (MDR) 
Clinical 
isolate
f  BHI, 37°C  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++ 
Bacillus cereus  ATCC 
11778  BHI, 37°C  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++ 
Streptococcus 
mutans 
DSM 
20523  BHI, 37°C  ++  +++ +++  ++  ++  ++  ++  ++  +++  ++  +++ +++ 
Gram-negative pathogenic bacteria 
Escherichia coli  ATCC 
11775  BHI, 37°C  ++  ++  ++  ++  ++  +++  ++  ++  ++  ++  ++  ++ 
Escherichia coli 
(MDR) 
Clinical 
isolate  BHI, 37°C  −  −  +  −  −  −  −  −  −  −  ++  − 
Salmonella 
Typhi 
ATCC 
6539  NB
e, 37°C  +++ +++ +++  ++  +++ +++ +++ +++ +++ +++ +++ +++ 
Pseudomonas 
aeruginosa 
ATCC 
9027  BHI, 37°C  +++  ++  +++ +++  ++  ++  ++  ++  +++  ++  +++  ++ 
Pseudomonas 
aeruginosa 
ATCC 
27853  BHI, 37°C  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++ 
Klebsiella 
pneumoniae 
Clinical 
isolate  BHI, 37°C  ++  ++  +++  ++  ++  ++  ++  ++  +++  ++  ++  ++ 
Shigella 
flexneri 
Clinical 
isolate  NB, 37°C  +  +  ++  ++  ++  +++  ++  ++  +++  ++  ++  +++ 
Inhibition zone Diameter: +++ = >14mm; ++ = 11-14mm; + = 8-10mm; - = no inhibition. MDR: Multidrug-
resistant; 
a: DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, 
Germany; 
b: ATCC: American Type Culture Collection, Manassas, VA, USA; 
c: de Man, Rogosa and Sharpe; 
d: 
Brain Heart Infusion; 
e: Nutrient Broth; 
f:Isolates from Centre Pasteur of Yaoundé, Cameroon. 198  P. M. Kaktcham et al.:   
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Experimental 
Samples, bacterial strains and growth conditions. 
Fifteen and 20 samples respectively of “Kossam” and “Sha’a” were collected directly and 
aseptically from local producers in three localities of Cameroon’s western highlands 
region. For lactic acid bacteria isolation, 1% (v/v) of each sample added to MRS broth (de 
Man Rogosa and Sharpe, Biolife, Milano, Italy) and incubated for 24 h at 30 °C was used 
to streak the surface of MRS agar plates. The plates were then incubated anaerobically 
(Genbox anaer; BioMérieux, France) at 30 °C for 48 h. Well-developed individual colonies 
on these plates were randomly picked and purified on MRS agar. These isolates were 
characterized based on the morphological characteristics, gram staining and catalase 
reaction [7]. The lactobacilli strains were kept in MRS broth plus glycerol (70:30) at −20 °C 
and were subcultured two times in MRS broth for activation prior to experimental use.  
The reference strains for Rep –  PCR analysis were obtained from Institut National de 
Recherche Agronomique (INRA), Centre de Recherche Zootechnique Jouy – en Josas, 
France (CNRZ) and American Type Culture Collection (ATCC).  
Food borne spoilage and pathogenic bacteria (Proteus mirabilis  and those listed in 
Table 5) used as indicator in testing antimicrobial activity were cultured at 37 °C and 
maintained on Mueller Hinton Agar (MHA, Conda, Madrid, Spain) slants. 
Inhibition of the growth of other lactobacilli and pathogenic bacteria 
The LAB isolates were tested for inhibition of the growth of other lactobacilli and some 
pathogenic bacteria using the spot on the lawn test as described by Geis et al. [8]. An 
aliquot (2 µl) of an overnight LAB culture was spotted onto MRS agar plates and incubated 
anaerobically at 30 °C for 48 h. The plates were subsequently overlaid with soft MRS agar 
(0.75% agar) or soft MHA containing 1% indicator strains, respectively, and then incubated 
anaerobically at 30 °C or aerobically at 37 °C, on the basis of the tested organisms, for 
24 h. Only isolates showing the largest inhibition diameter zones were selected for the 
next steps. 
Strains identification using physiological and biochemical methods  
The 21 selected isolates were identified to species level using their carbohydrate pattern 
obtained with API 50 galleries (BioMérieux, Marcy l’Etoile France). Tests were performed 
according to the manufacturer’s instructions. Interpretations of the fermentation profiles 
were facilitated by systematically comparing all results obtained from the isolates studied 
with information from the computer-aided database APILAB plus V.3.2.2.  
Rep-PCR genomic fingerprinting 
Total DNA was extracted from 1.6 ml of fresh cultures in the exponential growth phase 
using the Wizard DNA purification Kit as described by the manufacturer (Promega). 
Amplification of DNA and separation of PCR products were performed according to the 
method described by Mohammed et al. [9]. The Rep profiles were processed using the Gel 
Compar version 5.00 software (Applied Maths, Kortrijk, Belgium). 
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Screening of Lactobacillus strains for bacteriocin production 
The Lactobacillus strains were screened for bacteriocin production using the Triple-agar 
layer method described by Todorov and Dicks [10], with the difference that buffered MRS 
medium (0.2 M potassium phosphate buffer, pH 7.0) was used and no antibiotic was 
added. 
Cell-free supernatants (CFS) of the selected producer strains were  screened for 
bacteriocin activity by the agar well diffusion assay (AWDA) as described by Schillinger 
and Lücke [11]. A 15-h-old culture (2% v/v) of each lactobacilli strain was inoculated in 
buffered MRS broth and incubated anaerobically at 30 °C for 10 h. The cultures were 
centrifuged (7,000 rpm, 30 min, 4 °C) and the supernatants collected, treated at 80 °C for 
10 min [12] and then tested for their activity by the AWDA. In another set of experiments, 
the CFS were incubated for 2 h at 37 °C in the presence of 1.0 mg/ml (final concentration) 
of Trypsin (in 0.05 M Tris-HCl buffer, pH 8.0, Fluka Biochemika), Proteinase K (in 0.05 M 
phosphate buffer, pH 7.0, Merck) α-Amylase (in 0.05 M phosphate buffer, pH 7.0, Sigma-
Aldrich), Lipase (in 0.05 M phosphate buffer, pH 7.0, Sigma-Aldrich) and Lysozyme (in 
0.05 M phosphate buffer, pH 7.0, Fluka Biochemika) and then tested for antimicrobial 
activity by AWDA.  
Safety attributes of bacteriocin-producing strains 
The safety attributes studied were haemolytic activity, gelatinase activity and antibiotic 
susceptibility.  
Haemolytic activity was investigated as described by Gerhardt et al. [13]. A 16-hour-old 
broth culture was streaked onto sterile blood agar plates. Plates were incubated 
anaerobically at 30 °C for 48 h. The haemolytic reactions were recorded by observation of 
a clear zone around the colonies (β-haemolysis), a partial hydrolysis and greening zone 
(α-haemolysis) or no reaction (γ-haemolysis) [14]. 
Gelatinase activity was investigated as described by Harrigan  and Mc Cance [15]. A 
16-hour-old culture was streaked onto nutrient gelatin agar (Oxoid). The plates were 
incubated anaerobically for 48 h at 30 °C after which they were flooded with a saturated 
ammonium sulfate solution and observed for clear zones surrounding colonies. 
Antibiotic susceptibility was tested by disk diffusion and by broth micro-dilution methods 
[16–17], using LSM broth and agar as test media (LSM consists of a mixture of Iso-
Sensitest medium, Oxoid Ltd). Incubation was done at 30 °C for 48 h. The MIC (µg/ml) 
was defined as the lowest antibiotic concentration that resulted in no visible growth. For 
disc diffusion antibiotic susceptibility, inhibition zone diameters (IZD) were measured and 
strains were classified as sensitive (IZD ≥ 21mm), intermediate (16mm ≤ IZD ≤ 20mm), 
and resistant (IZD ≤ 15mm) according to interpretative standards defined by CLSI [18] and 
Vlková  et al.  [19]. The MICs (µg/ml) were determined and the results of susceptibility 
status were interpreted according to the recent FEEDAP document of the European Food 
Safety Authority (EFSA) on the update of the criteria used in the assessment of antibiotics 
bacterial resistance of human or veterinary importance [5] as well as epidemiological cut-
off values defined by the ACE – ART Project results, ISO 10932 [20]. Strains showing 
MICs less than EFSA’s breakpoints were considered sensitive; otherwise, they were 
resistant. The following antibiotics obtained from Oxoid were tested: penicillin G, ampicillin, 200  P. M. Kaktcham et al.:   
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ciprofloxacin, tetracycline, erythromycin, amoxicillin, gentamicin, chloramphenicol, 
co-trimoxazole, and doxycyclin.  
Spectrum of inhibitory activity of bacteriocin-producing strains 
The antibacterial activities of the samples were tested against Gram-positive and Gram-
negative bacteria (listed in table 5). The indicator strains (0.5 Mc Farland suspensions) 
were inoculated in the appropriate soft agar media and the antibacterial activities were 
determined by AWDA. Experiments were conducted in triplicate. 
Acknowledgement 
This study received the financial supports of the AUF Central Africa Regional office and 
TWAS. The authors thank the research assistants of the Microbial Biochemistry 
Laboratory (University of Alexandria-Egypt) for their helpful assistance during the 
identification of LAB, and ICCBS, University of Karachi-Pakistan for Laboratory facilities 
during screening for bacteriocin-producing strains. 
Authors’ Statement 
Competing Interests 
The authors declare no conflict of interest. 
References 
[1]  Marteau P, Rambaud JC.  
Potential of using lactic acid bacteria for therapy and immunomodulation in man.  
FEMS Microbiol Rev. 1993; 12: 207–220.  
http://dx.doi.org/10.1111/j.1574-6976.1993.tb00019.x 
[2]  Klaenhammer TR.  
Bacteriocins of lactic acid bacteria.  
Biochimie. 1988; 70: 337–349. 
http://dx.doi.org/10.1016/0300-9084(88)90206-4 
[3]  Bromberg R, Moreno I, Zaganini CL, Delboni RR, De Oliveira J.  
Isolation of bacteriocin-producing lactic acid bacteria from meat and meat products and its spectrum of 
inhibitory activity.  
Braz J Microbiol. 2004; 35: 137–144. 
http://dx.doi.org/10.1590/S1517-83822004000100023 
[4]  Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M.  
Antibiotic resistance – the interplay between antibiotic use in animals and human beings.  
Lancet Infect Dis. 2003; 3: 47–51. 
http://dx.doi.org/10.1016/S1473-3099(03)00490-0 
[5]  EFSA.  
Technical guidance. Update of the criteria used in the assessment of bacterial resistance to antibiotics 
of human or veterinary importance.  
The EFSA Journal. 2008; 732: 1–15. 
[6]  Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G.  
Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and 
Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods.  
J Appl Microbiol. 2000; 89: 815–824. 
http://dx.doi.org/10.1046/j.1365-2672.2000.01187.x   Antimicrobial and Safety Properties of Lactobacilli  201 
Sci Pharm. 2012; 80: 189–203 
[7]  Harrigan WF, Mc Cance ME.  
Laboratory methods.  
In: Food and Dairy Microbiology. 
Harigan WF, Mc Cance ME; eds.  
Academic press. New York, USA. 1976: 12–15. 
[8]  Geis A, Singh J, Teuber M.  
Potential of lactic streptococci to produce bacteriocin.  
Appl Environ Microbiol. 1983; 45: 205–211. 
http://www.ncbi.nlm.nih.gov/pubmed/16346166 
[9]  Mohammed M, Abd El-Aziz H, Omran N, Anwar S, Awad S, El-Soda M.  
Rep-PCR characterization and biochemical selection of lactic acid bacteria isolated from the Delta 
area of Egypt.  
Int J Food Microbiol. 2009; 128: 417–423. 
http://dx.doi.org/10.1016/j.ijfoodmicro.2008.09.022 
[10]  Todorov SD, Dicks LMT.  
Lactobacillus plantarum isolated from molasses produces bacteriocins active against Gram-negative 
bacteria.  
Enz Microb Technol. 2005; 36: 318–326. 
http://dx.doi.org/10.1016/j.enzmictec.2004.09.009 
[11]  Schillinger U, Lücke F.  
Antibacterial activity of Lactobacillus sake isolated from meat.  
Appl Environ Microbiol. 1989; 55: 1901–1906. 
http://www.ncbi.nlm.nih.gov/pubmed/2782870 
[12]  Todorov SD, Dicks LMT.  
Bacteriocin production by Pediococcus pentosaceus isolated from marula (Scerocarya birrea).  
Int J Food Microbiol. 2009; 132: 117–126. 
http://dx.doi.org/10.1016/j.ijfoodmicro.2009.04.010 
[13]  Gerhardt P, Murray RG, Costilow RN, Nester EW, Wood WA, Krieg NR, Phillips GB.  
Manual of methos for general bacteriology.  
American society for Microbiology, Washington, DC 20006. 1981. 
[14]  De Vuyst L, Foulquie Moreno MR, Revets H.  
Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of 
different origins. 
Int J Food Microbiol. 2003; 84: 299–318. 
http://dx.doi.org/10.1016/S0168-1605(02)00425-7 
[15]  Harrigan WF, Mc Cance ME.  
Laboratory Methods in Food and Dairy Microbiology.  
Academic Press, London. 1990. 
[16]  Clinical and Laboratory Standards Institute.  
Performance standards for antimicrobial disc susceptibility test; Approved standard-Tenth Edition. 
CLSI document M02-A10 (ISBN 1-56238-688-3). Clinical and Laboratory Standards Institute, 940 
West Valley Road, suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009. 
[17]  Clinical and Laboratory Standards Institute.  
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved 
standard-Eight Edition. CLSI document M07-A8 (ISBN 1-56238-689-1). Clinical and Laboratory 
Standards Institute, 940 West Valley Road, suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009. 
[18]  Clinical and Laboratory Standards Institute. 
Performance standards for antimicrobial susceptibility testing. Twenty-First Informational Supplement”. 
CLSI document M100-S21. Wayne, PA; Clinical and Laboratory Standards Institute, 2011. 202  P. M. Kaktcham et al.:   
Sci Pharm. 2012; 80: 189–203 
[19]  Vlková E, Rada V, Popelářová P, Trojanová I, Killer J.  
Antimicrobial susceptibility of bifidobacteria isolated from gastrointestinal tract of calves.  
Livest Sci. 2006; 105: 253–259. 
http://dx.doi.org/10.1016/j.livsci.2006.04.011 
[20]  ISO 10932 / IDF 223. Milk and milk products – Determination of minimal inhibitory concentration (MIC) 
of antibiotics applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB). 2010. 
[21]  Diop MB, Dubois-Dauphin R, Tine E, Ngom A, Destain J, Thonart P.  
Bacteriocin producers from traditional food products.  
Biotechnol Agron Soc Environ. 2007; 11: 275–281. 
[22]  Todorov SD.  
Bacteriocin production by Lactobacillus plantarum AMA-K isolated from Amasi, a Zimbabwean 
fermented milk product and study of adsorption of bacteriocin AMA-K to Listeria spp.  
Braz J Microbiol. 2008; 38: 178−187. 
http://dx.doi.org/10.1590/S1517-83822008000100035 
[23]  Chagnaud P, Machinis K, Coutte LA, Marecat A, Mercenier A. 
Rapid PCR-based procedure to identify lactic acid bacteria: application to six common Lactobacillus 
species.  
J Microbiol Methods. 2001; 44: 139–148. 
http://dx.doi.org/10.1016/S0167-7012(00)00244-X 
[24]  Terzic-Vidojevic A, Tolinacki M, Nikolic M, Lozo J, Begovic J, Gulahmadov SG, Kuliev AA, 
Dalgalarrondo M, Chobert JM, Haertlé T, Topisirovic L.  
Phenotypic and genotypic characterization of lactic acid bacteria isolated from Azerbaijani traditional 
dairy products. 
Afr J Biotechnol. 2009; 8: 2576–2588. 
[25]  Todorov SD, Prévost H, Lebois M, Dousset X, Le Blanc JG, Franco BD.  
Bacteriocinogenic Lactobacillus plantarum ST16Pa isolated from papaya (Carica papaya) — From 
isolation to application: Characterization of a bacteriocin.  
Food Res Inter. 2011; 44: 1351–1363. 
http://dx.doi.org/10.1016/j.foodres.2011.01.027 
[26]  Anas M, Jamal H, Eddine, Mebrouk K.  
Antimicrobial activity of Lactobacillus species isolated from Algerian raw Goat’s milk against 
Staphylococcus aureus.  
World J Dairy Food Sci. 2008; 3: 39–49. 
[27]  Kalui CM, Mathara JM, Kutima PM, Kiiyukia C, Wongo LE.  
Functional characteristics of Lactobacillus plantarum and Lactobacillus rhamnosus from ikii, a Kenyan 
traditional fermented maize porridge.  
Afr J Biotechnol. 2009; 8: 4363–4373. 
[28]  Comunian R, Daga E, Dupré I, Paba A, Devirgiliis C, Piccioni V, Perozzi G, Zonenschain D, 
Rebecchi A, Morelli L, De Lorentiis A, Giraffa G.  
Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from 
traditional Italian fermented foods.  
Int J Food Microbiol. 2010; 138: 151–156. 
http://dx.doi.org/10.1016/j.ijfoodmicro.2009.11.018 
[29]  Elkins CA, Mullis LB.  
Bile-mediated aminoglycoside sensibility in Lactobacillus species likely results from increased 
membrane permeability attributable to cholic acid.  
Appl Environ Microbiol. 2004; 70: 7200–7209. 
http://dx.doi.org/10.1128/AEM.70.12.7200-7209.2004   Antimicrobial and Safety Properties of Lactobacilli  203 
Sci Pharm. 2012; 80: 189–203 
[30]  Herreros MA, Fresno JM, Sandoval H, Gonzáles L, Castro JM, Tornadijo ME.  
Antimicrobial activity and antibiotic resistance of lactic acid bacteria isolated from Armada cheese (a 
Spanish goats’ milk cheese).  
Food Microbiol. 2004; 22: 455–459. 
http://dx.doi.org/10.1016/j.fm.2004.11.007 
[31]  Rojo-Bezares B, Sáenz Y, Poeta P, Zarazaga M, Ruiz-Larrea F, Torres C.  
Assessment of antibiotic susceptibility within lactic acid bacteria strains isolated from wine.  
Int J Food Microbiol. 2006; 111: 234–240. 
http://dx.doi.org/10.1016/j.ijfoodmicro.2006.06.007 
[32]  Mathur S, Singh R.  
Antibiotic resistance in food lactic acid bacteria – A review.  
Int J Food Microbiol. 2005; 105: 281–295. 
http://dx.doi.org/10.1016/j.ijfoodmicro.2005.03.008 
[33]  French GL.  
Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin.  
J Antimicrob Chemother. 2006; 58: 1107–1117. 
http://dx.doi.org/10.1093/jac/dkl393 
 